Menu Content/Inhalt
Debio 025
   Order     Display # 
Date Item Title
01-Apr-2008 Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent
15-Mar-2008 Genetic and Pharmacologic Inhibition of Mitochondrial-dependent Necrosis Atte uates Muscular Dystrophy
11-Mar-2008 The Cyclophilin Inhibitor Debio-025 Shows Potent Anti-Hepatitis C Effect in Patients Coinfected with Hepatitis C and Human Immunodeficiency Virus
25-Jan-2008 In vivo & in vitro effects of Debio 025 in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy
13-Dec-2007 The Role of Cyclophilins and Cyclophilin Inhibitors in the Replication of HCV
23-Nov-2007 The cyclophilin inhibitor Debio 025 is a potent inhibitor of Hepatitis C virus replication in vitro and has unique resistance profile
29-Aug-2007 Cyclophilin inhibitors in Hepatitis C viral Infection
24-Apr-2007 Evaluation of a cyclophilin inhibitor in Hepatitis C virus-infected chimeric mice in vivo
14-Apr-2007 Viral Kinetics During 14-day Treatment with Debio-025 Demonstrate Efficient Blocking of Viral Replication in Different HCV Genotypes without Signs of Emerging Viral Resistance
11-Apr-2007 The Reduction of both Cyclophilin B and HCV-RNA by the Cyclophilin Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for HCV replication in Man
31-Mar-2007 Low Risk of Drug Interaction between the Cyclophilin Inhibitor Debio-025 and (Peg) IFNa/ribavirin in HCV
31-Oct-2006 The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naïve HIV/HCV co-infected subjects
27-Oct-2006 Non-immunosuppressive Cyclosporin Debio-025 with Interferon shows synergistic Anti-HCV Effect in Chimeric Mouse
24-Sep-2006 Selective inhibitors of Hepatitis C virus replication
02-Sep-2006 Postconditioning and Debio-025 Prevent LV Remodelling and Reduce Mortaility Following Acute Myocardial Infarction in Mice
30-Aug-2006 Cyclosporine increases Human Immunodeficiency virus Type 1 Vector Transduction of Primary Mouse Cells
01-Jul-2006 In Vivo and in Vitro Effects of Debio-025, a non-immunosuppressive Cyclosporin A Derivative on Duchene Muscular Dystrophy
24-Jun-2006 Hepatoprotection by Cyclosporin A in Experimental Hepatitis. Sorting Desensitization of the Mitochondrial Permeablility Transition Pore from Immunosuppression
21-May-2006 The non-immunosuppressive Cyclosporin A analogue Debio-025 is a potent inhibitor of Hepatitis C virus replication in vitro
25-Apr-2006 Debio-025 is a Promising New Drug for the Treatment of Chronic Hepatitis C
 
< Prev 1 2 Next >
Results 1 - 20 of 28